cancer was declared in 1971. We assess the contribution of pharmaceutical innovation to the increase in cancer survival rates …

We investigate the effect of therapeutic procedure innovation in general on the longevity of all hospital patients, i … patient-level data indicate that therapeutic procedure innovation increased the life expectancy of WA hospital patients by …-level data also indicate that therapeutic procedure innovation increased the life expectancy of WA hospital patients, but the …

I analyze the effects of four types of medical innovation and cancer incidence on U.S. cancer mortality rates during … that there were no pre‐dated factors that drove both innovation and mortality and that there would have been parallel … trends in mortality in the absence of innovation, the estimates indicate that there were three major sources of the 13 …

the health of Americans during the period 1990-2003. We hypothesize that, the more medical innovation there is related to … hypothesis, we estimate models of health outcomes using longitudinal disease-level data. We measure innovation in five types of … outpatient drug innovation had larger increases in mean age at death, controlling for other medical innovation rates and initial …